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Do Vitamin C Supplements Reduce Cardiovascular Disease Mortality? 
Searchable Question 
Do vitamin C supplements reduce mortality in patients with cardiovascular disease? 
Evidence-Based Answer 
Vitamin C, when taken as a dietary supplement, does not appear to reduce mortality in patients 
with cardiovascular disease. [Strength of recommendation: B, based on reviews of cohort studies 
and a single randomized controlled trial (RCT)] 
Evidence Summary 
It has been suggested that antioxidant nutrients, such as vitamin C, may play a role in reducing 
cardiovascular disease. Several cohort studies and one RCT have evaluated the effectiveness of 
antioxidants in reducing mortality associated with cardiovascular disease.1-5 [References 1 
through 4-Level of evidence: 1A, based on systematic review of cohort studies] 
Seven large cohort studies involving more than 4,000 patients assessed various antioxidants and 
their effect on cardiovascular disease mortality.3 Dosages were different in the studies, and the 
results were inconsistent. Only two of these studies showed a relative risk reduction (RR). 
The first of these two studies, the National Health and Nutrition Examination Survey 
(NHANES), included 11,348 patients who were taking more than 50 mg of vitamin C per day, 
which resulted in an RR of 48 percent (range: 31 to 61 percent) in cardiovascular disease 
mortality. The second of the two studies included 5,133 patients in Finland who were taking 
more than 90 mg of vitamin C per day, which resulted in an RR of 51 percent (range: 2 to 68 
percent). 
The remaining five studies included 102,735 patients taking various doses of vitamin C but 
showed no effect on cardiovascular disease mortality.2 
The Chinese Cancer Prevention Trial5 (the only completed RCT of vitamin C) studied 39,584 
patients who were taking more than 250 mg of vitamin C per day. This study demonstrated no 
effect on prevention of cardiovascular disease mortality. 
Several clinical trials involving thousands of patients are currently examining major 
cardiovascular events (e.g., myocardial infarction) and mortality, and the use of antioxidants for 
prevention of cardiovascular disease. It is hoped that the results of these trials will further 
elucidate the role of antioxidant supplementation in treating and preventing cardiovascular 
disease.2 
The U.S. Preventive Services Task Force (USPSTF) conducted a systematic review of the 
studies on vitamin C and found the evidence inconclusive because the studies were inadequate 
and conflicting.1 
Recommendations from Others 
According to the USPSTF, there is insufficient evidence to recommend vitamin supplements for 
the prevention of cardiovascular disease.1 The American Heart Association recommends a diet 
rich in antioxidants but concludes that there is insufficient evidence for any specific 
recommendations for vitamin supplementation.6 
Clinical Commentary 
Many primary care physicians and cardiologists continue to recommend vitamin C for 
prevention of cardiovascular disease mortality, so you may encounter some resistance from 
patients if you decline to support this supplementation. In situations like this, it may be helpful to 
explain that while we once thought it was a good idea, newer studies have shown that it "just 
didn't pan out." 
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